Trinefron (goldenrod, rosemary, lovage) oral drops 100 ml. vial

Description

Trinefron (goldenrod, rosemary, lovage) oral drops 100 ml. vial

Composition

active substance: 1 g (27 drops) of the drug contains liquid extract from medicinal plant raw materials: goldenrod (Herba Centaurii), rosemary (Folia Rosmarini officinalis), lovage (Radix Levistici officinalis) (1: 1: 1) 1:16) (extractant: ethanol 59%), – 290 mg;

excipient (except extractant) purified water.

Dosage form

Oral drops.

Main physical and chemical properties: clear, slightly turbid yellow-brown liquid with a specific odor. Slight opalescence or slight precipitation during storage is allowed.

Pharmacotherapeutic group

Means used in urology.
ATX code G04B X.

Pharmacological properties

The ingredients that make up the drug are of plant origin and demonstrate complex activity. The drug has anti-inflammatory, antispasmodic, antioxidant and analgesic effects. In addition, the drops have antibacterial and diuretic effects.

Indications

Trinefron oral drops are used as part of the complex treatment of inflammatory lesions of the urinary tract. Also, the drug is used to prevent the development of urolithiasis and prevent the formation of calculi in the kidneys and bladder after their removal or spontaneous exit.

Contraindications

It is necessary to avoid prescribing the drug to patients who suffer from hypersensitivity to its ingredients or other plants that belong to the Umbrella class.
In addition, the drug is contraindicated in patients who suffer from ulcerative lesions of the intestines and stomach in the acute stage.
Trinefron oral drops are not prescribed to patients who have edema associated with heart or renal failure.
Due to the presence of ethyl alcohol in the drops, they are not used in the therapy of patients who suffer from alcohol dependence or have undergone a course of anti-alcohol therapy. In addition, one should refrain from prescribing the drug to patients who drive potentially dangerous machinery or vehicles.
If, when taking the drops, the patient has a fever, spasms, symptoms of urinary disorders or blood in the urine, then you should immediately seek help from a doctor.

Application during pregnancy and lactation

In the process of studying the drug, no teratogenic or mutagenic action was revealed in it, however, due to the limited experience of using the drug in the therapy of pregnant women, its appointment to this category of patients is carried out only as a last resort.
Taking drops is not compatible with breastfeeding.

Method of administration and dosage

Patients take the drug 50 drops three times a day. Trinefron oral drops can be taken either in pure or diluted form. It is recommended to shake the product thoroughly before use to achieve an even distribution of medicinal substances in the solution.
Treatment with the drug should be accompanied by the intake of a sufficient amount of liquid.
The duration of therapy in each case is determined by the doctor individually.

Overdose

When taking drops in high doses, the patient may experience symptoms of alcohol intoxication. Treatment is symptomatic.

Side effects

The use of drops can be accompanied by disruption of the digestive system, manifested by the occurrence of dyspeptic disorders. Also, when taking the drug, some patients may experience local allergic reactions, which are characterized by the occurrence of skin rashes, urticaria, itching and irritation.